NSQAP: Program Reports
Annual Summary and Midyear QC Reports
- 2016 Annual Summary Report [PDF – 4 MB]
- 2017 Set 1 Quality Control Program Report (Amended) [PDF – 3 MB]
- 2016 Set 2 Quality Control Program Report [PDF – 2 MB]
- 2016 Set 1 Quality Control Program Report [PDF – 1 MB]
- 2015 Annual Summary Report (Amended) [PDF – 4 MB]
- 2015 Midyear QC Report [PDF – 6 MB]
- 2014 Annual Summary Report [PDF – 14 MB]
- 2014 Midyear QC Report [PDF – 4 MB]
- Filter Paper Comparison Study [PDF – 313 KB]
Quarterly Proficiency Testing Reports
Anti-HIV-1
- 2017 August – Quarter 3 [PDF – 2 MB]
- 2017 May – Quarter 2 [PDF – 2 MB]
- 2017 February – Quarter 1 [PDF – 2 MB]
- 2016 November – Quarter 4 [PDF – 2 MB]
- 2016 August – Quarter 3 [PDF – 1 MB]
- 2016 May – Quarter 2 [PDF – 1 MB]
- 2016 February – Quarter 1 [PDF – 976 KB]
- 2015 November – Quarter 4 [PDF – 1 MB]
- 2015 August – Quarter 3 [PDF – 1,001 KB]
- 2015 May – Quarter 2 [PDF – 915 KB]
- 2015 February – Quarter 1 [PDF – 435 KB]
Cystic Fibrosis Mutation Detection
- 2017 May – Quarter 2 [PDF – 2 MB]
- 2017 February – Quarter 1 [PDF – 2 MB]
- 2016 November – Quarter 4 [PDF – 2 MB]
- 2016 August – Quarter 3 [PDF – 1 MB]
- 2016 May – Quarter 2 [PDF – 1 MB]
- 2016 February – Quarter 1 [PDF – 1 MB]
- 2015 November – Quarter 4 [PDF – 1 MB]
- 2015 August – Quarter 3 [PDF – 1 MB]
- 2015 May – Quarter 2 [PDF – 1 MB]
- 2015 February – Quarter 1 [PDF – 908 KB]
Lysosomal Storage Disorder
- 2017 August – Quarter 3 [PDF – 2 MB]
- 2017 February – Quarter 1 [PDF – 2 MB]
- 2016 November – Quarter 4 [PDF – 2 MB]
- 2016 August – Quarter 3 [PDF – 1 MB]
- 2016 May – Quarter 2 [PDF – 1 MB]
- 2016 February – Quarter 1 [PDF – 611 KB]
- 2015 November – Quarter 4 [PDF – 1 MB]
- 2015 August – Quarter 3 (Amended) [PDF – 852 KB]
- 2015 May – Quarter 2 [PDF – 432 KB]
- 2015 February – Quarter 1 [PDF – 693 KB]
Second-tier LC-MS/MS for CAH
- 2017 August – Quarter 3 [PDF – 2 MB]
- 2017 February – Quarter 1 [PDF – 2 MB]
- 2016 November – Quarter 4 (Amended) [PDF – 2 MB]
- 2016 August – Quarter 3 [PDF – 1 MB]
- 2016 February – Quarter 1 [PDF – 890 KB]
- 2015 November – Quarter 4 [PDF – 1 MB]
- 2015 August – Quarter 3 [PDF – 1 MB]
- 2015 February – Quarter 1 [PDF – 637 KB]
Sickle Cell/Hemoglobins
- 2017 May – Quarter 2 [PDF – 2 MB]
- 2017 February – Quarter 1 [PDF – 907 KB]
- 2016 November – Panel 3 [PDF – 2 MB]
- 2016 June – Panel 2 [PDF – 827 KB]
- 2016 February – Panel 1 [PDF – 930 KB]
- 2015 November – Panel 3 (Amended) [PDF – 1 MB]
- 2015 June – Panel 2 [PDF – 851 KB]
- 2015 February – Panel 1 [PDF – 690 KB]
Toxoplasma Antibodies
- 2017 August – Quarter 3 [PDF – 2 MB]
- 2017 May – Quarter 2 [PDF – 2 MB]
- 2017 February – Quarter 1 [PDF – 2 MB]
- 2016 November – Quarter 4 [PDF – 2 MB]
- 2016 August – Quarter 3 [PDF – 1 MB]
- 2016 May – Quarter 2 [PDF – 1 MB]
- 2016 February – Quarter 1 [PDF – 1 MB]
- 2015 November – Quarter 4 [PDF – 1 MB]
- 2015 August – Quarter 3 [PDF – 1 MB]
- 2015 May – Quarter 2 [PDF – 419 KB]
- 2015 February – Quarter 1 [PDF – 670 KB]
- 2015 January – Quarter 4 [PDF – 487 KB]
TREC
- 2017 August – Quarter 3 (Amended) [PDF – 2 MB]
- 2017 August – Quarter 3 [PDF – 2 MB]
- 2017 February – Quarter 1 [PDF – 2 MB]
- 2016 November – Quarter 4 [PDF – 2 MB]
- 2016 August – Quarter 3 [PDF – 1 MB]
- 2016 May – Quarter 2 [PDF – 1 MB]
- 2016 February – Quarter 1 [PDF – 1 MB]
- 2015 November – Quarter 4 [PDF – 777 KB]
- 2015 August – Quarter 3 [PDF – 1 MB]
- 2015 May – Quarter 2 [PDF – 548 KB]
- 2015 February – Quarter 1 [PDF – 756 KB]
UDOT
XALD
- Page last reviewed: July 6, 2017
- Page last updated: October 4, 2017
- Content source: